Edgewise Therapeutics, Inc. (EWTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 10:34AM EDT. Market open.
| Previous close | 17.39 |
| Open | 17.77 |
| Bid | 17.21 x 200 |
| Ask | 17.44 x 100 |
| Day's range | 17.15 - 17.84 |
| 52-week range | 5.12 - 21.60 |
| Volume | |
| Avg. volume | 603,664 |
| Market cap | 1.618B |
| Beta (5Y monthly) | 0.13 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.54 |
| Earnings date | 08 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 33.60 |
- GuruFocus.com
Edgewise Therapeutics Inc (EWTX) Reports First Quarter 2024 Financial Results
Performance Analysis and Future Clinical Prospects
Business WireEdgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 15, 2024
BOULDER, Colo., May 10, 2024--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that management will present at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 15, 2024, at 3:35 pm ET.
Business WireEdgewise Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
BOULDER, Colo., May 09, 2024--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today reported financial results for the first quarter of 2024 and recent business highlights.
© 2024 Yahoo. All rights reserved.